Travere Therapeutics Inc

NASDAQ:TVTX   9:30:33 AM EDT
25.82
+0.12 (+0.47%)
Other Pre-Announcement

Travere Therapeutics Sees FY Revenue $227 Million

Published: 01/10/2022 13:01 GMT
Travere Therapeutics Inc (TVTX) - Sees FY Revenue $227 Million.
FY2021 Revenue View $227.3 Million -- Refinitiv Ibes Data (analyst estimates).